Skip to main content
FinSpry Logo
FinSpry
PHAR logo
PHAR
(NASDAQ)
Pharming Group N.V.
$10.95-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Pharming Group (PHAR) Stock Price & Financial Analysis

Pharming Group Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$11.31 - $12.34
52-Week High$21.34
52-Week Low$9.62
Open$11.46
Volume89.77K
Average Volume (3M)10.98K
Market Cap820.72M
Shares Outstanding74.95M
P/E Ratio (TTM)88.87
Price to Sales (P/S)2.22
Price to Book (P/B)3.03
EV/EBITDA-19.37
Revenue (TTM)369.45M
Net Income (TTM)9.23M
Free Cash Flow (TTM)34.04M
EPS (TTM)$0.13
Profit Margin2.50%
Operating Margin-17.15%
Return on Equity (ROE)3.41%
Debt to Equity0.34
50-Day MA$12.71
200-Day MA$15.36
52-Week Change-17.23%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Pharming Group

What is the current stock price for PHAR?

As of the latest trading session, PHAR stock trades at $12.23. The 52-week range is $9.62–$21.34, with a day range of $11.31–$12.34.

What is the P/E ratio for PHAR?

Pharming Group's trailing P/E ratio is 88.9, meaning investors pay $88.9 for every $1 of annual earnings. Pharming Group operates in the Healthcare sector.

Does PHAR pay dividends?

Pharming Group does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PHAR?

Analyst ratings and recommendations for PHAR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of PHAR?

Pharming Group's market capitalization is $916.7M, classifying it as a small-cap company. Pharming Group operates in the Healthcare sector within the Biotechnology industry.